REFERENCES
- Rose B, Post T, eds. Clinical Physiology of Acid-Base and Electrolyte Disorders. 5th ed., New York: McGraw-Hill; 2001.
- Hilleman D, Miller MA, Parker R, Doering P, Pieper JA. Optimal management of amiodarone therapy: Efficacy and side effects. Pharmacotherapy. 1998;18:138S–145S.
- Wilson JS, Podrid PJ. Side effects from amiodarone. Am Heart J. 1991;121:158–171.
- Odeh M, Schiff E, Oliven A. Hyponatremia during therapy with amiodarone. Arch Intern Med. 1999;159:2599–2600.
- Ikegami H, Shiga T, Tsushima T, Nirei T, Kasanuki H. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by amiodarone: A report on two cases. J Cardiovasc Pharmacol Ther. 2002;7:25–28.
- Patel GP, Kasiar JB. Syndrome of inappropriate antidiuretic hormone-induced hyponatremia associated with amiodarone. Pharmacotherapy. 2002;22:649–651.
- Aslam MK, Gnaim C, Kutnick J, Kowal RC, McGuire DK. Syndrome of inappropriate antidiuretic hormone secretion induced by amiodarone therapy. Pacing Clin Electrophysiol. 2004;27:831–832.
- Shavit E, Sherer Y. Hyponatremia induced by amiodarone therapy. Isr Med Assoc J. 2007;9:564–565.
- Paydas S, Araz F, Balal M. SIADH induced by amiodarone in a patient with heart failure. Int J Clin Pract. 2008;62:337.